LALINDEN ADVISORS LP

Institutional investor · Portfolio as of Q4 2020

Top Holdings481 positions

Checking export access…
Activity:
??PINDUODUO INCDelisted
Bond
296.8M$1.2B9.2%——
2 qtrssince 2020-Q3
Decreased
0
??MERCADOLIBRE INCDelisted
Bond
241.6M$918.4M6.9%——
6 qtrssince 2019-Q3
Decreased
0
??SEA LTDDelisted
Bond
204.9M$812.3M6.1%———
New
98
??BILIBILI INCDelisted
Bond
148.8M$515.5M3.9%——
3 qtrssince 2020-Q2
Decreased
0
??ZILLOW GROUP INCDelisted
Bond
156.1M$467M3.5%———
New
87
??SNAP INC
Bond
187.3M$424.9M3.2%——
2 qtrssince 2020-Q3
Increased
86
??ZILLOW GROUP INCDelisted
Bond
136.6M$411.4M3.1%——
2 qtrssince 2020-Q3
Decreased
0
??EXACT SCIENCES CORPDelisted
Bond
285M$372.2M2.8%——
4 qtrssince 2020-Q1
Decreased
0
182.6M$306.8M2.3%——
2 qtrssince 2020-Q3
Increased
67
??PENN NATL GAMING INCDelisted
Bond
76.4M$288.8M2.2%——
3 qtrssince 2020-Q2
Increased
64
??CHEGG INCDelisted
Bond
149.7M$272M2.0%——
3 qtrssince 2020-Q2
Decreased
0
??COUPA SOFTWARE INCDelisted
Bond
107.5M$234.3M1.8%——
3 qtrssince 2020-Q2
Decreased
0
??ZILLOW GROUP INCDelisted
Bond
108.6M$226.4M1.7%——
2 qtrssince 2020-Q3
Increased
73
??PINDUODUO INCDelisted
Bond
170.5M$210.7M1.6%———
New
70
??SPLUNK INCDelisted
Bond
146.9M$198.5M1.5%——
6 qtrssince 2019-Q3
Decreased
0
??BLACKLINE INCDelisted
Bond
102.7M$193.2M1.4%——
2 qtrssince 2020-Q3
Increased
51
??ETSY INC
Bond
76.3M$161.9M1.2%——
2 qtrssince 2020-Q3
Increased
53
??Q2 HLDGS INCDelisted
Bond
102.5M$157.2M1.2%——
3 qtrssince 2020-Q2
Increased
48
??GDS HLDGS LTDDelisted
Bond
77.9M$147.5M1.1%——
7 qtrssince 2019-Q2
Decreased
0
149M$142.5M1.1%——
8 qtrssince 2019-Q1
Decreased
0
$13.4B
AUM
481
Positions
Q4 2020
Filing
HI score · 2.0/5
Quarterly 13F Value Change
+14%Q3'19$7.4B+14%Q4'19$8.4B-33%Q1'20$5.6B+9%Q2'20$6.1B+34%Q3'20$8.2B+62%Q4'20$13.3B
Activity profile
$ moved · Q4'20
New49%Increased14%Decreased21%Exited16%
Composition
Equity vs derivatives
Equity99%Puts0%Calls0%
Holding period
Avg 1.5 quarters
<1Q59%1-4Q21%1-2Y20%2Y+0%

LINDEN ADVISORS LP manages $13.4B across 481 positions as of Q4 2020. Top holdings: PINDUODUO INC (9.2%), MERCADOLIBRE INC (6.9%), SEA LTD (6.1%). Fund DNA: Diversified Scout. HoldingsIntel Score: 2/5.0.

Q4 2020 Summary

Active quarter - 289 new positions, 130 exits, 37 increased. No standout high-conviction moves this quarter. Portfolio: $13.4B across 481 positions.

Portfolio Allocation

Top holdings by portfolio weight

Total AUM$13B
PINDUODUO IN9.24%
MERCADOLIBRE6.87%
SEA LTD6.07%
BILIBILI INC3.85%
ZILLOW GROUP3.49%
SNAP INC3.18%
ZILLOW GROUP3.08%
EXACT SCIENC2.78%
WAYFAIR INC2.29%
PENN NATL GA2.16%
Other2.03%
Sector Breakdown

Portfolio allocation by GICS sector

Sectors11
Unknown71.67%
Financial Services6.30%
Consumer Cyclical5.23%
Technology4.64%
Healthcare3.67%
Industrials3.66%
Basic Materials1.91%
Real Estate1.61%
Consumer Defensive0.73%
Communication Services0.56%
Other0.01%
Fund DNA

Behavioral investing profile

Checking access…
Diversified Scout
Compare DNA across all funds
HoldingsIntel Score
7-dimension, SEC 13F-derived research score
Below Average(2.0 / 5.0)
Holdings P&L57
Conviction31
Concentration37
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Top Losers

Checking access…

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

HBK INVESTMENTS L PHBK INVESTMENTS L P
$8.6B
Dynasty Wealth Management, LLCDynasty Wealth Management, LLC
$13.5B
Checking access…

Explore More

Compare LINDEN ADVISORS LP
Side-by-side holdings comparison
High-Conviction Picks
Top conviction positions this quarter
Double-Down Detection
Buying into price weakness
Best Trades
Top performing positions by P&L
All Diversified Scout Funds
Investing archetypes and behavior

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
BR10806XAD4BRIDGEBIO PHARMA INC
Q4 2024 → Q2 2026+151.4M shares+$192.5M
7Q
VI928298AR9VISHAY INTERTECHNOLOGY INC
Q4 2024 → Q2 2026+353.9M shares+$770.5M
4Q
CO19459JAC8COLLEGIUM PHARMACEUTICAL INC
Q3 2025 → Q2 2026+26.6M shares+$50.6M
Checking access…

Continue exploring

Explore high-conviction positions
See which stocks have the strongest institutional commitment
Compare with similar funds
Find portfolio overlap with LINDEN ADVISORS LP
Clone this fund
Backtest what copying LINDEN ADVISORS LP's portfolio would return

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used